Author:
Barthur Ashita,Brezden-Masley Christine,Connelly Kim A.,Dhir Vinita,Chan Kelvin K. W.,Haq Rashida,Kirpalani Anish,Barfett Joseph J.,Jimenez-Juan Laura,Karur Gauri R.,Deva Djeven P.,Yan Andrew T.
Funder
Canadian Institutes of Health Research
Roche Canada
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference33 articles.
1. American Cancer Society. Cancer Facts & Figures 2015. Cancer Facts Fig 2015. 2015;1–9.
2. Canadian Cancer Society. Canadian Cancer Statistics Special topic : Predictions of the future burden of cancer in Canada. Public Heal Agency Canada. 2015;1–151.
3. Krishnamurti U, Silverman JF. HER2 in breast cancer: a review and update. Adv Anat Pathol. 2014;21:100–7.
4. Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014;32:2100–8.
5. Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, Murphy M, Stewart SJ, Keefe D. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol. 2002;20:1215–21.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献